المؤلفون: Dominique Berton, Anne Floquet, Willy Lescaut, Gabriel Baron, Marie-Christine Kaminsky, Philippe Toussaint, Rémy Largillier, Aude-Marie Savoye, Jérôme Alexandre, Catherine Delbaldo, Emmanuelle Malaurie, Hugues Barletta, Claire Bosacki, Claire Garnier-Tixidre, Philippe Follana, Hortense Laharie-Mineur, Charles Briac Levache, Bruno Valenza, Agnès Dechartres, Delphine Mollon-Grange, Frédéric Selle

المصدر: Frontiers in Pharmacology, Vol 12 (2021)

مصطلحات موضوعية: bevacizumab, ovarian cancer, routine clinical practice, monitoring, progression-free survival, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2021.711813/full; https://doaj.org/toc/1663-9812

URL الوصول: https://doaj.org/article/759e5d59f76b40d9ba13a0b2c9ebd372

المؤلفون: E. Malaurie, Claire Bosacki, Aude-Marie Savoye, Claire Garnier-Tixidre, Philippe Toussaint, Agnès Dechartres, Rémy Largillier, Gabriel Baron, Marie-Christine Kaminsky, Dominique Berton, Bruno Valenza, Willy Lescaut, Hortense Laharie-Mineur, Jérôme Alexandre, Anne Floquet, Frédéric Selle, Charles Briac Levache, Hugues Barletta, Philippe Follana, Delphine Mollon-Grange, Catherine Delbaldo

المساهمون: Institut de Cancérologie de l'Ouest [Angers/Nantes] (UNICANCER/ICO), UNICANCER, Institut Bergonié [Bordeaux], Centre Hospitalier Princesse Grace, Centre d'épidémiologie Clinique [Hôtel-Dieu], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hôpital Hôtel Dieu, Institut de Cancérologie de Lorraine - Alexis Vautrin [Nancy] (UNICANCER/ICL), Centre Léon Bérard [Lyon], Centre Azuréen de Cancérologie [Mougins, France], Institut Jean Godinot [Reims], Hôpital Cochin [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Groupe Hospitalier Diaconesses Croix Saint-Simon, Centre Hospitalier Intercommunal de Créteil (CHIC), Institut de Cancérologie de la Loire Lucien Neuwirth, Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne), Groupe Hospitalier Mutualiste [Grenoble] (GHM), Centre de Lutte contre le Cancer Antoine Lacassagne [Nice] (UNICANCER/CAL), UNICANCER-Université Côte d'Azur (UCA), Clinique Tivoli Ducos [Bordeaux], Clinique Francheville [Périgueux], Service de gynécologie [Centre hospitalier intercommunal Fréjus Saint-Raphaël], Centre Hospitalier Intercommunal Fréjus - St Raphaël (CHI Fréjus - St Raphaël), CHU Charles Foix [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Centre Hospitalier Intercommunal de Cornouaille (CHIC), Gestionnaire, HAL Sorbonne Université 5

المصدر: Frontiers in Pharmacology
Frontiers in Pharmacology, Frontiers, 2021, 12, ⟨10.3389/fphar.2021.711813⟩
Frontiers in Pharmacology, Vol 12 (2021)

مصطلحات موضوعية: medicine.medical_specialty, genetic structures, Bevacizumab, Identifier NCT01832415 bevacizumab, Population, RM1-950, bevacizumab, law.invention, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, medicine, Pharmacology (medical), 030212 general & internal medicine, Progression-free survival, education, Prospective cohort study, Pharmacology, education.field_of_study, business.industry, Brief Research Report, Carboplatin, 3. Good health, Clinical trial, monitoring, ovarian cancer, routine clinical practice, chemistry, Tolerability, [SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, 030220 oncology & carcinogenesis, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Clinical Trial Registration: ClinicalTrials.gov, Therapeutics. Pharmacology, business, progression-free survival, medicine.drug

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cf7a8cd1710e52fe5eebb4d3d33d65f
https://pubmed.ncbi.nlm.nih.gov/34616296

المؤلفون: Jérôme, Barrière, Clarisse, Audigier-Valette, Delphine, Borchiellini, Benjamin, Hoch, Olivier, Castelnau, Eric, Francois, Lauris, Gastaud, Richard, Skaf, Jean-François, Berdah, Wislez, Marie, Willy, Lescaut, Frédéric, Peyrade, Thomas, Cluzeau, Ophélie, Cassuto, Michel, Carles

المصدر: Bulletin du Cancer

مصطلحات موضوعية: Immunocompromised Host, COVID-19 Vaccines, Immunization Programs, SARS-CoV-2, Neoplasms, Age Factors, Immunization, Secondary, COVID-19, Humans, France, Immunization Schedule, Tribune Libre

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::66791d45291eee62e73096b6d2580e0c
https://pubmed.ncbi.nlm.nih.gov/33741139

المؤلفون: Thomas Cluzeau, Olivier Castelnau, Jérôme Barrière, Richard Skaf, J. F. Berdah, Michel Carles, Delphine Borchiellini, Frederic Peyrade, Eric Francois, Clarisse Audigier-Valette, Willy Lescaut, Lauris Gastaud, Wislez Marie, Benjamin Hoch, Ophelie Cassuto

المصدر: Bulletin du Cancer. 108:341-342

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, Schedule, 2019-20 coronavirus outbreak, Coronavirus disease 2019 (COVID-19), business.industry, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Cancer, Neoplasms therapy, Hematology, General Medicine, medicine.disease, Supply & distribution, Immunization, Internal medicine, medicine, Radiology, Nuclear Medicine and imaging, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::2ea8219530c9119914073b8b0e501a88
https://doi.org/10.1016/j.bulcan.2021.02.003

المؤلفون: Marie J Chammas, Emily Pesek, Robert J. Soiffer, Veronika Bachanova, Abraham Avigdor, Joseph H. Antin, Armando Santoro, Philippe Armand, Willy Lescaut, Anne Thiebaut-Bertrand, Stephen M. Ansell, Jerome Ritz, Pier Luigi Zinzani, Reid W. Merryman, Ahmad Halwani, Miguel-Angel Perales, Scott C. Bresler, Harim Kim, L. Castagna, Amitabh Srivastava, Vincent T. Ho, Haesook T. Kim, Roch Houot, Aspasia Stamatoullas-Bastard, Carol Reynolds, Pierre-Simon Rohrlich, Carmelo Carlo-Stella, Nathalie Dhedin, Hélène Labussière Wallet, Tony Marchand, Sylvie François

المساهمون: Merryman, Reid W., Kim, Haesook T., Zinzani, Pier Luigi, Carlo-Stella, Carmelo, Ansell, Stephen M., Perales, Miguel-Angel, Avigdor, Abraham, Halwani, Ahmad S., Houot, Roch, Marchand, Tony, Dhedin, Nathalie, Lescaut, Willy, Thiebaut-Bertrand, Anne, François, Sylvie, Stamatoullas-Bastard, Aspasia, Rohrlich, Pierre-Simon, Wallet, Hélène Labussière, Castagna, Luca, Santoro, Armando, Bachanova, Veronika, Bresler, Scott C., Srivastava, Amitabh, Kim, Harim, Pesek, Emily, Chammas, Marie, Reynolds, Carol, Ho, Vincent T., Antin, Joseph H., Ritz, Jerome, Soiffer, Robert J., Armand, Philippe, Service d'hématologie clinique, Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Hôpital Pontchaillou, Microenvironment, Cell Differentiation, Immunology and Cancer (MICMAC), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Hôpital Saint-Louis, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Centre Hospitalier Princesse Grace de Monaco (CHPG), Monaco, Clinique Universitaire d'Hématologie [La Tronche, Grenoble], Centre Hospitalier Universitaire [Grenoble] (CHU), Service des maladies du sang [Angers], Centre Hospitalier Universitaire d'Angers (CHU Angers), PRES Université Nantes Angers Le Mans (UNAM)-PRES Université Nantes Angers Le Mans (UNAM), Centre de Lutte Contre le Cancer Henri Becquerel Normandie Rouen (CLCC Henri Becquerel), Hôpital l'Archet, Hospices Civils de Lyon (HCL), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Istituto Clinico Humanitas [Milan] (IRCCS Milan), Humanitas University [Milan] (Hunimed), Department of Oncology and Hematology, Humanitas Cancer Center, University of Minnesota [Twin Cities] (UMN), University of Minnesota System, Harvard Medical School [Boston] (HMS), Seoul National University College of Medicine, Dana-Farber Cancer Institute [Boston], L. and A. Seràgnoli Hospital, University of Bologna, University of Milan, Mayo Clinic [Rochester], Memorial Sloane Kettering Cancer Center [New York], Chaim Sheba Medical Center, Huntsman Cancer Institute [Salt Lake City], University of Utah, Université de Rennes (UR)-Hôpital Pontchaillou, Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Structure Fédérative de Recherche en Biologie et Santé de Rennes ( Biosit : Biologie - Santé - Innovation Technologique ), Alma Mater Studiorum Università di Bologna [Bologna] (UNIBO), Università degli Studi di Milano = University of Milan (UNIMI), Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-Université Paris Diderot - Paris 7 (UPD7), University of Minnesota [Twin Cities]

المصدر: Blood
Blood, American Society of Hematology, 2017, 129 (10), pp.1380-1388. ⟨10.1182/blood-2016-09-738385⟩
Blood, 2017, 129 (10), pp.1380-1388. ⟨10.1182/blood-2016-09-738385⟩

مصطلحات موضوعية: Adult, Male, medicine.medical_specialty, Lymphoma, medicine.medical_treatment, Immunology, Programmed Cell Death 1 Receptor, [SDV.CAN]Life Sciences [q-bio]/Cancer, Antineoplastic Agents, Hematopoietic stem cell transplantation, Kaplan-Meier Estimate, Antibodies, Monoclonal, Humanized, Gastroenterology, Biochemistry, Disease-Free Survival, Statistics, Nonparametric, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Immune system, Internal medicine, medicine, Cytotoxic T cell, Humans, Aged, Retrospective Studies, Transplantation, business.industry, Hematopoietic Stem Cell Transplantation, Antibodies, Monoclonal, Hematology, Cell Biology, Middle Aged, medicine.disease, Allografts, Combined Modality Therapy, 3. Good health, Blockade, Nivolumab, 030220 oncology & carcinogenesis, Monoclonal, Female, Neoplasm Recurrence, Local, business, 030215 immunology

وصف الملف: ELETTRONICO

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7be36b519c34b9ebc42d3160174216b3
https://europepmc.org/articles/PMC5345733/